Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Journal of Clinical Microbiology
|
November 12, 2010
Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers
Franziska A Stressmann, Geraint B Rogers, Erich R Klem, et al.
The ISME Journal
|
November 30, 2012
Reducing bias in bacterial community analysis of lower respiratory infections
Geraint B Rogers, Leah Cuthbertson, Lucas R Hoffman, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 14, 2011
Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?
Franziska A Stressmann, Geraint B Rogers, Peter Marsh, et al.
Molecular Pharmaceutics
|
May 1, 2020
Antibiotic-in-Cyclodextrin-in-Liposomes: Formulation Development and Interactions with Model Bacterial Membranes
Kalliopi-Kelli A Vandera, Pietro Picconi, Margarita Valero, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 2, 2012
TRPV1 deletion enhances local inflammation and accelerates the onset of systemic inflammatory response syndrome
Elizabeth S Fernandes, Lihuan Liang, Sarah-Jane Smillie, et al.
Journal of Medical Microbiology
|
October 1, 2021
2-Alkyl-4-quinolone quorum sensing molecules are biomarkers for culture-independent <i>Pseudomonas aeruginosa</i> burden in adults with cystic fibrosis
Nur Masirah M Zain, Karmel Webb, Iain Stewart, et al.
The Journal of Allergy and Clinical Immunology
|
February 8, 2021
Gut microbiota development during infancy: Impact of introducing allergenic foods
Tom Marrs, Jay-Hyun Jo, Michael R Perkin, et al.
International Journal of Pharmaceutics
|
May 12, 2025
Bacterial diversity, viability and stability in lyophilised faecal microbiota capsules support ongoing clinical use
Nur Masirah M Zain, Blair Merrick, Thomas Martin-Lilley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 30, 2013
Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis
Daniel J Wolter, Julia C Emerson, Sharon McNamara, et al.
Journal of Hepatology
|
September 27, 2021
Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial
Vishal C Patel, Sunjae Lee, Mark J W McPhail, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Journal of Clinical Microbiology
|
November 12, 2010
Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers
Franziska A Stressmann, Geraint B Rogers, Erich R Klem, et al.
The ISME Journal
|
November 30, 2012
Reducing bias in bacterial community analysis of lower respiratory infections
Geraint B Rogers, Leah Cuthbertson, Lucas R Hoffman, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 14, 2011
Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?
Franziska A Stressmann, Geraint B Rogers, Peter Marsh, et al.
Molecular Pharmaceutics
|
May 1, 2020
Antibiotic-in-Cyclodextrin-in-Liposomes: Formulation Development and Interactions with Model Bacterial Membranes
Kalliopi-Kelli A Vandera, Pietro Picconi, Margarita Valero, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 2, 2012
TRPV1 deletion enhances local inflammation and accelerates the onset of systemic inflammatory response syndrome
Elizabeth S Fernandes, Lihuan Liang, Sarah-Jane Smillie, et al.
Journal of Medical Microbiology
|
October 1, 2021
2-Alkyl-4-quinolone quorum sensing molecules are biomarkers for culture-independent <i>Pseudomonas aeruginosa</i> burden in adults with cystic fibrosis
Nur Masirah M Zain, Karmel Webb, Iain Stewart, et al.
The Journal of Allergy and Clinical Immunology
|
February 8, 2021
Gut microbiota development during infancy: Impact of introducing allergenic foods
Tom Marrs, Jay-Hyun Jo, Michael R Perkin, et al.
International Journal of Pharmaceutics
|
May 12, 2025
Bacterial diversity, viability and stability in lyophilised faecal microbiota capsules support ongoing clinical use
Nur Masirah M Zain, Blair Merrick, Thomas Martin-Lilley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 30, 2013
Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis
Daniel J Wolter, Julia C Emerson, Sharon McNamara, et al.
Journal of Hepatology
|
September 27, 2021
Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial
Vishal C Patel, Sunjae Lee, Mark J W McPhail, et al.
Page
of 7